all to do with the fat report and nothing else, page-12

I'm with JimmyC on this one, in order for TOX to be revalued to around $1.80, this would have to be a much larger acquisition than previous ones while also having a low EBITDA multiple. I felt TOX had run too hard on no news and that was why I sold out at $1.79, hoping to possibly re-enter on a retrace. I guess I will find out by Monday whether it was a good move or not.